Koki Matsuo

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.

Yoshito Naiki, Yasuhiro Maeda, Koki Matsuo et al. · PubMed · 2003 · 33 citations

Medicine, Molecular Medicine, Nephrology +11

Impact of endoplasmic reticulum stress on oocyte aging mechanisms

Isao Takehara, Hideki Igarashi, Jun Kawagoe et al. · Molecular Human Reproduction · 2020 · 28 citations

Life Sciences, Cell Biology, Developmental Biology +17

Possible Effects of Hepatocyte Growth Factor for the Prevention of Peritoneal Fibrosis

Koki Matsuo, Yasuhiro Maeda, Yoshito Naiki et al. · Nephron Experimental Nephrology · 2005 · 22 citations

Medicine, Biochemistry, Pathology +11

Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis

Toshiaki Matsuoka, Yasuhiro Maeda, Koki Matsuo et al. · Journal of Nephrology · 2008 · 20 citations

Medicine, Pathobiology, Pathology +11